Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.

By T. Yau, Vikki Tang, T. Yao, S. Fan, C. Lo, R. Poon. Gastroenterology, 2014

659 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology, Surgery

View Paper: https://www.semanticscholar.org/paper/d4cb265e1794f020749ef64bef10b6768e62886d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Kudo
2. R. Finn
3. Jorge Marrero
4. Lewis R. Roberts
5. Andrew X. Zhu
6. Claude B. Sirlin
7. J. Heimbach
8. L. Kulik

In Hepatology

1. M. Kudo
2. A. Cheng
3. R. Finn
4. Jorge Marrero
5. Lewis R. Roberts
6. Andrew X. Zhu
7. Claude B. Sirlin
8. J. Heimbach

Citations in the corpus

• Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017, methodology): “The Hong Kong treatment algorithm recommends LR for those with early tumor (B5 cm, B3 tumor nodules, no intrahepatic venous invasion) and intermediate tumor ([1] B5 cm, either[3 tumor nodules or with intrahepatic venous invasion, or [2][5 cm, 3 tumor nodules, and no intrahepatic venous invasion) [41”
• AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023, neutral): “…with BCLC Stage B. [150] The HKLC system initially had nine stages, which were condensed to five stages to allow more nuanced stratification in intermediate-and advanced-stage HCC. [ 151 ] 147] combination therapies and transitions between types of therapies during follow-up follow-up — related”
• Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2019, background): “The Hong Kong Liver Cancer (HKLC) staging classification has been proposed as a more granular staging system for HCC with improved discriminatory ability.(98) Compared with the BCLC, the HKLC potentially distinguishes differential prognosis between patients with mild tumor-related symptoms and those”
• Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2018, background): “The Hong Kong Liver Cancer (HKLC) staging classification has been proposed as a more granular staging system for HCC with improved discriminatory ability.(98) Compared with the BCLC, the HKLC potentially distinguishes differential prognosis between patients with mild tumor-related symptoms and those”